Show simple item record

dc.contributor.authorOst, Natalie K.
dc.contributor.authorMinchew, Heather M.
dc.contributor.authorGarcia, Andrew
dc.contributor.authorGanatra, Hammad A.
dc.date.accessioned2022-11-17T19:15:53Z
dc.date.available2022-11-17T19:15:53Z
dc.date.issued2022-08-17
dc.identifier.citationOst NK, Minchew HM, Garcia A, Ganatra HA. COVID-19 in a mosaic trisomy 13 patient with polycystic kidney disease. SAGE Open Medical Case Reports. 2022;10. doi:10.1177/2050313X221118732en_US
dc.identifier.urihttp://hdl.handle.net/1808/33670
dc.descriptionA grant from the One-University Open Access Fund at the University of Kansas was used to defray the author's publication fees in this Open Access journal. The Open Access Fund, administered by librarians from the KU, KU Law, and KUMC libraries, is made possible by contributions from the offices of KU Provost, KU Vice Chancellor for Research & Graduate Studies, and KUMC Vice Chancellor for Research. For more information about the Open Access Fund, please see http://library.kumc.edu/authors-fund.xml.
dc.description.abstractPresentation, management, and outcomes of COVID-19 infections among younger patients is an area of medicine with deficits in research, likely due to the lower incidence of severe COVID-19 disease among the younger population. Management can be challenging, and clinicians often guide their decision-making based on the ever-changing protocols that are tailored mostly to the elderly population. Even more underrepresented in COVID-19 research are patients with chromosomal abnormalities and trisomy syndromes, as they appear less frequently, but have risk of increased morbidity and mortality due to underlying medical conditions. We describe a case of severe COVID-19 infection in a young patient with mosaic trisomy 13 and pre-existing polycystic kidney disease, who developed severe acute hypoxic respiratory failure and acute chronic kidney injury. The patient was provided maximal pharmacological support and her clinical course helps to shape the understanding of COVID-19 infections in the setting of chromosomal abnormalities and complex medical history.en_US
dc.publisherSAGE Publicationsen_US
dc.rights© The Author(s) 2022. This article is distributed under the terms of the Creative Commons Attribution NonCommercial 4.0 License.en_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/en_US
dc.subjectCOVID-19en_US
dc.subjectTrisomy 13en_US
dc.subjectMosaicen_US
dc.subjectPatau syndromeen_US
dc.subjectPolycystic kidney diseaseen_US
dc.titleCOVID-19 in a mosaic trisomy 13 patient with polycystic kidney diseaseen_US
dc.typeArticleen_US
kusw.kuauthorMinchew, Heather M.
kusw.kuauthorGanatra, Hammad A.
kusw.kudepartmentUniversity of Kansas Medical Centeren_US
dc.identifier.doi10.1177/2050313X221118732en_US
dc.identifier.orcidhttps://orcid.org/0000-0001-8836-8085en_US
dc.identifier.orcidhttps://orcid.org/0000-0001-9534-2780en_US
kusw.oaversionScholarly/refereed, publisher versionen_US
kusw.oapolicyThis item meets KU Open Access policy criteria.en_US
dc.rights.accessrightsopenAccessen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

© The Author(s) 2022. This article is distributed under the terms of the Creative Commons Attribution NonCommercial 4.0 License.
Except where otherwise noted, this item's license is described as: © The Author(s) 2022. This article is distributed under the terms of the Creative Commons Attribution NonCommercial 4.0 License.